MREO
Mereo BioPharma Group plc
$0.33
$0.00(0.00%)
36
Overall
--
Value
36
Tech
--
Quality
Market Cap
$51.20M
Volume
1.26M
52W Range
$0.20 - $3.05
Target Price
$1.75
Order:
Income Statement
| Metric | Trend | Chart | 2024 Mar | 2024 Sep | 2024 Dec | 2025 Mar |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $9.9M | $9.4M | $47.4M | $11.2M | ||
| Research & Development | $4.0M | $3.2M | $20.9M | $3.9M | ||
| Research Expense | $4.0M | $3.2M | $20.9M | $3.9M | ||
| Selling, General & Administrative | $5.9M | $6.2M | $26.4M | $7.3M | ||
| General & Administrative Expenses | $5.9M | $6.2M | $26.4M | $7.3M | ||
| OPERATING INCOME | ||||||
| Operating income | $-9.9M | $-9.4M | $-47.4M | $-11.2M | ||
| EBITDA | $-8.7M | $-14.6M | $-40.8M | $-12.4M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $310.0K | $353.0K | $1.4M | $180.0K | ||
| Intinc | $617.0K | $983.0K | $3.0M | $659.0K | ||
| Net Non-Operating Interest Income/Expense | $307.0K | $630.0K | $1.7M | $479.0K | ||
| Other Income/Expense | $-925.0K | $-167.0K | $-1.2M | $-601.0K | ||
| Other Special Charges | $477.0K | $226.0K | $1.6M | $185.0K | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-9.0M | $-14.6M | $-41.9M | $-12.7M | ||
| Pre-Tax Income | $-9.3M | $-15.0M | $-43.3M | $-12.9M | ||
| NET INCOME | ||||||
| Net Income | $-9.3M | $-15.0M | $-43.3M | $-12.9M | ||
| Net Income (Continuing Operations) | $-9.3M | $-15.0M | $-43.3M | $-12.9M | ||
| Net Income (Discontinued Operations) | $-9.3M | $-15.0M | $-43.3M | $-12.9M | ||
| Net Income (Common Stockholders) | $-9.3M | $-15.0M | $-43.3M | $-12.9M | ||
| Normalized Income | $-9.2M | $-14.9M | $-42.8M | $-12.8M | ||
| TOTALS | ||||||
| Total Expenses | $9.9M | $9.4M | $47.4M | $11.2M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $140.1M | $154.0M | $147.9M | $156.9M | ||
| Average Shares Outstanding (Diluted) | $140.1M | $154.0M | $147.9M | $156.9M | ||
| Shares Outstanding | $40.3B | $154.7M | $155.1M | $159.0M | ||
| Basic EPS | $-0.05 | $-0.10 | $-0.30 | $-0.10 | ||
| Basic EPS (Continuing Operations) | $-0.05 | $-0.10 | $-0.30 | $-0.10 | ||
| Diluted EPS | $-0.01 | $-0.10 | $-0.30 | $-0.10 | ||
| Diluted EPS (Continuing Operations) | $-0.01 | $-0.10 | $-0.30 | $-0.10 | ||
| OTHER METRICS | ||||||
| Other Gand A | $5.9M | $6.2M | $26.4M | $7.3M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MREO | $0.33 | 0% | 1.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mereo BioPharma Group plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW